Odomzo Alternatives Compared
Odomzo | Fluorouracil topical | Imiquimod topical |
|
---|
Odomzo (sonidegib) | Fluorouracil topical | Imiquimod topical |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Basal Cell Carcinoma. Odomzo may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Actinic Keratosis, Basal Cell Carcinoma, Keratosis, Warts, Skin Cancer. fluorouracil topical may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Basal Cell Carcinoma, Human Papilloma Virus, Keratosis, Molluscum Contagiosum, Condylomata Acuminata. imiquimod topical may also be used for purposes not listed in this medication guide. View more |
||||||||||||||||||||||||
More about Odomzo (sonidegib) | More about Fluorouracil topical | More about Imiquimod topical | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Odomzo has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Fluorouracil topical has an average rating of 7.5 out of 10 from a total of 294 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 15% reported a negative effect. |
Imiquimod topical has an average rating of 7.0 out of 10 from a total of 448 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Odomzo side effects in more detail. |
See also: fluorouracil topical side effects in more detail. |
See also: imiquimod topical side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Odomzo prices |
View all fluorouracil topical prices |
View all imiquimod topical prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Carac, Efudex, Efudex Occlusion Pack, Fluoroplex, Tolak | Aldara, Zyclara | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
672 hours |
N/A |
N/A |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 174 drugs are known to interact with Odomzo:
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 6 drugs are known to interact with imiquimod topical:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
July 24, 2015 |
July 29, 1970 |
February 27, 1997 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.